Creo Medical Group PLC - Asset Resilience Ratio
Creo Medical Group PLC (CREO) has an Asset Resilience Ratio of -0.29% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Creo Medical Group PLC's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2023)
This chart shows how Creo Medical Group PLC's Asset Resilience Ratio has changed over time. See CREO equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Creo Medical Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Creo Medical Group PLC.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-200.00K | -0.29% |
| Total Liquid Assets | GBX-200.00K | -0.29% |
Asset Resilience Insights
- Limited Liquidity: Creo Medical Group PLC maintains only -0.29% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Creo Medical Group PLC Industry Peers by Asset Resilience Ratio
Compare Creo Medical Group PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Creo Medical Group PLC (2020–2023)
The table below shows the annual Asset Resilience Ratio data for Creo Medical Group PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 20.23% | GBX15.50 Million ≈ $1.89K |
GBX76.60 Million ≈ $9.32K |
+20.44pp |
| 2022-12-31 | -0.20% | GBX-153.00K ≈ $-18.62 |
GBX75.34 Million ≈ $9.17K |
-0.08pp |
| 2020-12-31 | -0.12% | GBX-112.00K ≈ $-13.63 |
GBX92.46 Million ≈ $11.25K |
-- |
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices deli… Read more